Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $15.0800 (5.82%) ($14.1400 - $15.3100) on Tue. Jul. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 46 | Latest Price | $15.0800(5.82%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | AUTL declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(20%) IBB(19%) ARKG(18%) SKYY(16%) IWF(15%) | Factors Impacting AUTL price | AUTL will decline at least -2.09% in a week (0% probabilities). VIXM(-11%) TBT(-7%) VXX(-6%) UNG(-4%) SHY(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | 0 () | Intraday Trend | 5.6% | | | |
|
5 Day Moving Average | $15.29(-1.37%) | 10 Day Moving Average | $15.27(-1.24%) | 20 Day Moving Average | $15.08(0%) | To recent high | -6.6% | To recent low | 84.4% | Market Cap | $788m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |